Loading page
Loading page
Loading substance route
Classified as habit-forming. As a substituted cathinone stimulant believed to have similar effects to mephedrone, it likely carries comparable psychological addiction potential, though little is known about its safety profile.
Little is known about the safety of 4-MEC, and no specific lethal dosage data is available. The possibility of overdose is noted as a concern, particularly with intravenous administration.
Intravenous use is reported to be rough on veins and sometimes accompanied by a burning sensation; users are advised to dilute the substance as much as possible to reduce venous irritation.
Visual and auditory hallucinations are listed among possible effects, suggesting some potential for perceptual disturbances, though specific data on psychotic episodes is not available.
4-MEC has been marketed commercially under the name "NRG-2," sold either as a standalone product or in mixtures containing other substituted cathinones. The compound has also been identified as an active ingredient in counterfeit ecstasy tablets, with reports from countries including New Zealand documenting its use as a substitute for MDMA in illicit pill markets.
Classified as a Schedule I controlled substance under the Controlled Substances Act, indicating high abuse potential with no currently accepted medical use in treatment.
8 sources cited